On Tuesday Walmart announced it would begin to help drug companies and research firms identify and recruit individuals to fill their clinical trials, reported Reuters.
Walmart Healthcare Research Institute will now find participants for clinical trials, and Walmart also hosts MyHealthJourney, a patient portal that helps people find upcoming research trials and track their care.
Walmart’s expansion into clinical trial recruitment could bring it new streams of revenue from drug companies.
John Wigneswaran, Walmart’s chief medical officer, said the retailer’s clinics and pharmacies will become a “funnel” for healthcare organizations that want access to its diverse populations of customers for possible trials and studies.
Patient-recruitment is difficult in clinical trials. Studies can be delayed or terminated when organizations are not able to get enough people to participate or when patients drop out of the trial.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI